<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Intermittent preventive antimalarial treatment for children with anaemia - Athuman, M - 2015 | Cochrane Library</title> <meta content="Intermittent preventive antimalarial treatment for children with anaemia - Athuman, M - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010767.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Intermittent preventive antimalarial treatment for children with anaemia - Athuman, M - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010767.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010767.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Intermittent preventive antimalarial treatment for children with anaemia" name="citation_title"/> <meta content="Mwaka Athuman" name="citation_author"/> <meta content="Ifakara Health Institute" name="citation_author_institution"/> <meta content="mkakolwa@ihi.or.tz" name="citation_author_email"/> <meta content="Abdunoor M Kabanywanyi" name="citation_author"/> <meta content="Ifakara Health Institute" name="citation_author_institution"/> <meta content="Anke C Rohwer" name="citation_author"/> <meta content="Stellenbosch University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD010767.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/01/13" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010767.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010767.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010767.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anemia [blood, etiology, *prevention &amp; control]; Antimalarials [*therapeutic use]; Endemic Diseases [*prevention &amp; control]; Hemoglobin A [metabolism]; Iron Compounds [administration &amp; dosage]; Malaria [complications, *prevention &amp; control]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <meta content="" name="citation_fulltext_world_readable"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010767.pub2&amp;doi=10.1002/14651858.CD010767.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="8ranHhTh";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010767\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010767\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","fa"],languageCode:"en",accessStatus:"not-found",doi:"10.1002/14651858.CD010767.pub2",title:"Intermittent preventive antimalarial treatment for children with anaemia",firstPublishedDate:"Jan 13, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Infectious Diseases Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010767.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010767.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010767.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010767.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010767.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010767.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010767.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010767.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010767.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010767.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1253 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010767.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-sec-0091"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-sec-0016"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-sec-0017"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-sec-0022"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-sec-0023"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-sec-0057"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-sec-0085"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/appendices#CD010767-sec-0096"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/table_n/CD010767StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/table_n/CD010767StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Authors. Cochrane Database of Systematic Reviews published by John Wiley &amp; Sons, Ltd. on behalf of The Cochrane Collaboration." data-creative-commons="true" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Intermittent preventive antimalarial treatment for children with anaemia</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/information#CD010767-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Mwaka Athuman</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/information#CD010767-cr-0003">Abdunoor M Kabanywanyi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010767.pub2/information#CD010767-cr-0004">Anke C Rohwer</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/information/en#CD010767-sec-0099">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 13 January 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010767.pub2">https://doi.org/10.1002/14651858.CD010767.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010767-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010767-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010767-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010767-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010767-abs-0001" lang="en"> <section id="CD010767-sec-0001"> <h3 class="title" id="CD010767-sec-0001">Background</h3> <p>Anaemia is a global public health problem. Children under five years of age living in developing countries (mostly Africa and South‐East Asia) are highly affected. Although the causes for anaemia are multifactorial, malaria has been linked to anaemia in children living in malaria‐endemic areas. Administering intermittent preventive antimalarial treatment (IPT) to children might reduce anaemia, since it could protect children from new <i>Plasmodium</i> parasite infection (the parasites that cause malaria) and allow their haemoglobin levels to recover. </p> </section> <section id="CD010767-sec-0002"> <h3 class="title" id="CD010767-sec-0002">Objectives</h3> <p>To assess the effect of IPT for children with anaemia living in malaria‐endemic areas.</p> </section> <section id="CD010767-sec-0003"> <h3 class="title" id="CD010767-sec-0003">Search methods</h3> <p>We searched the Cochrane Infectious Diseases Group Specialized Register, Cochrane Central of Controlled Trials (CENTRAL), published in <i>The Cochrane Library</i>; MEDLINE; EMBASE; and LILACS. We also searched the World Health Organization (WHO) International Clinical Trial Registry Platform and metaRegister of Controlled Trials (mRCT) for ongoing trials up to 4 December 2014. </p> </section> <section id="CD010767-sec-0004"> <h3 class="title" id="CD010767-sec-0004">Selection criteria</h3> <p>Randomized controlled trials (RCTs) evaluating the effect of IPT on children with anaemia. </p> </section> <section id="CD010767-sec-0005"> <h3 class="title" id="CD010767-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data and assessed risk of bias. We analysed data by conducting meta‐analyses, stratifying data according to whether participants received iron supplements or not. We used GRADE to assess the quality of evidence. </p> </section> <section id="CD010767-sec-0006"> <h3 class="title" id="CD010767-sec-0006">Main results</h3> <p>Six trials with 3847 participants met our inclusion criteria. Trials were conducted in areas of low malaria endemicity (three trials), and moderate to high endemicity (three trials). Four trials were in areas of seasonal malaria transmission. Iron was given to all children in two trials, and evaluated in a factorial design in a further two trials. </p> <p>IPT for children with anaemia probably has little or no effect on the proportion anaemic at 12 weeks follow‐up (four trials, 2237 participants, (<i>moderate quality evidence</i>). </p> <p>IPT in anaemic children probably increases the mean change in haemoglobin levels from baseline to follow‐up at 12 weeks on average by 0.32 g/dL (MD 0.32, 95% CI 0.19 to 0.45; four trials, 1672 participants, <i>moderate quality evidence</i> ); and may improve haemoglobin levels at 12 weeks (MD 0.35, 95% CI 0.06 to 0.64; four trials, 1672 participants, <i>low quality evidence</i>). For both of these outcomes, subgroup analysis did not demonstrate a difference between children receiving iron and those that did not. </p> <p>IPT for children with anaemia probably has little or no effect on mortality or hospital admissions at six months (three trials, 3160 participants moderate quality evidence). Subgroup analysis did not show a difference between those children receiving iron supplements and those that did not. </p> </section> <section id="CD010767-sec-0007"> <h3 class="title" id="CD010767-sec-0007">Authors' conclusions</h3> <p>Trials did show a small effect on average haemoglobin levels but this did not appear to translate into an effect on mortality and hospital admissions. Three of the six trials were conducted in low endemicity areas where transmission is low and thus any protective effect is likely to be modest. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010767-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010767-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010767-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010767-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010767-abs-0004">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010767-abs-0003" lang="en"> <h3>Antimalarial drugs as a treatment of anaemia in children living in malaria‐endemic areas. </h3> <p>Children living in malaria areas may develop severe anaemia, often caused by malaria infection, and this can cause death if not treated properly. Intermittent preventive treatment (IPT) is a course of malaria treatment given regularly to these children in order to prevent infection and malaria illness. It has been suggested that IPT could be used to treat children with anaemia in these areas. We aimed to find all the studies looking at treating anaemic children with IPT in order to see what the overall effect is. We examined the evidence available up to 4 December 2014. </p> <p>We included six trials in this review, with a total number of 3847 participants. In all the trials, one group received IPT and the control group received placebo. Three trials were done in low malaria endemicity areas and the other three in high endemicity areas. In some trials, iron supplements were also given to children, which is also a treatment for anaemia, and we took this into consideration when analysing the data. </p> <p>Our results did not find that the number of children who died or were admitted to hospital was lower in the group receiving IPT, irrespective of whether they received iron (<i>moderate quality evidence</i> ); and there was no difference in the number of children with anaemia at the end of follow‐up (<i>moderate quality evidence</i> ). Average haemoglobin levels were higher in the IPT group compared to the placebo group, but the effect was modest (<i>low quality evidence</i>). </p> <p>Although our results show that there are small benefits in haemoglobin levels when treating anaemic children with IPT, we did not detect an effect on death or hospital admissions. However, three of the six included trials were conducted in low endemicity areas where malaria transmission is low and thus any protective effect is likely to be modest. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010767-sec-0091" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010767-sec-0091"></div> <h3 class="title" id="CD010767-sec-0092">Implications for practice</h3> <section id="CD010767-sec-0092"> <p>The trials did not demonstrate a difference in all‐cause mortality and hospital admissions at six months; and prevalence of anaemia at 12 weeks amongst children that received IPT compared to those that did not receive IPT. IPT probably increases the Hb levels of anaemic children. Despite the small benefits of IPT on Hb levels of anaemic children, it does not warrant routine administration of IPT to anaemic children. However, one needs to take into consideration that the majority of trials were conducted in low endemicity areas, where any effect is likely to be modest. </p> </section> <h3 class="title" id="CD010767-sec-0093">Implications for research</h3> <section id="CD010767-sec-0093"> <p>Only one trial was adequately powered to detect a difference in the risk of all‐cause mortality and hospital admissions due to severe anaemia or severe malaria. Future trials should be adequately powered to detect differences in patient‐orientated outcomes (for example, all‐cause mortality) and consideration should be given to malaria endemicity. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010767-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010767-sec-0016"></div> <div class="table" id="CD010767-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table 1</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Intermittent preventive treatment compared to placebo for children with anaemia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Children with anaemia<br/> <b>Settings:</b> Malaria‐endemic areas<br/> <b>Intervention:</b> IPT (± iron and folic acid)<br/> <b>Comparison:</b> Placebo (± iron and folic acid) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> IPT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death or hospital admission</b> </p> <p><b>Follow up at 6 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b> <br/> (24 to 38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.9</b> <br/> (0.71 to 1.13) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3160<br/> (3 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2,3,4</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Children with anaemia</b> <br/> <b>(Hb</b>  <b>&lt;</b>  <b>11 g/dL)</b> </p> <p><b>Follow up at 12 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>579 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>561 per 1000</b> <br/> (510 to 620) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b> <br/> (0.88 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2237<br/> (4 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,5,6,7</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in Hb from baseline</b> </p> <p><b>Follow up: 12 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change ranged across control groups from<br/> <b>0.32 to 5.4 g/dL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the intervention groups was<br/> <b>0.32 g/dL higher</b> <br/> (0.19 to 0.45 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1672<br/> (4 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,8,9,10</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean Hb</b> </p> <p><b>Follow up at 12 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean Hb concentration ranged across control groups from<br/> <b>9.91 to 10.7 g/dL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean Hb concentration in the intervention groups was<br/> <b>0.35 g/dL higher</b> <br/> (0.06 to 0.64 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1672<br/> (4 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>8,9,10,11</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median control group risk across trials. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>IPT:</b> intermittent preventive treatment; <b>AL:</b> artemether lumefantrine. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> No serious risk of bias: The largest trial was at low risk of bias. The two smaller trials were at high risk of attrition bias, but exclusion of these trials does not change the result.<br/> <sup>2</sup> No serious inconsistency: Statistical heterogeneity was low.<br/> <sup>3</sup> No serious indirectness: The three trials were conducted in the Gambia, Kenya and Malawi, one trial gave IPT (AL monthly) to children discharged from hospital following severe malarial anaemia, and two trials gave IPT (SP monthly) to anaemic children attending hospital, outpatient clinics or recruited in the community. There was no significant result for subgroup differences between areas with high versus areas with low endemicity.<br/> <sup>4</sup> Downgraded by 1 for serious imprecision: The 95% CI around the absolute risk difference is very narrow and excludes clinically important effects. However, much larger trials would be necessary to fully exclude small benefits with IPT.<br/> <sup>5</sup> Downgraded by 1 for serious risk of bias: high risk of attrition bias for <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> and <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>.<br/> <sup>6</sup> No serious indirectness: All the trials gave IPT (SP) monthly to anaemic children attending hospital, outpatient clinics or recruited in the community. There was no significant result for subgroup differences between areas with high versus areas with low endemicity.<br/> <sup>7</sup> No serious imprecision: No effect was seen and the meta‐analysis is adequately powered to detect an effect. </p> <p><sup>8</sup> No serious imprecision. A small effect was seen although this disappears when we removed trials at high risk of bias from the analysis.<br/> <sup>9</sup> Downgraded by 1 for serious risk of bias: High risk for attrition bias for <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> and <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>.<br/> <sup>10</sup> No serious indirectness: Three trials gave IPT (SP) monthly and one trial gave CQ weekly to anaemic children attending hospital, outpatient clinics or recruited in the community. There was no significant result for subgroup differences between areas with high versus areas with low endemicity.<br/> <sup>11</sup> Downgraded for serious inconsistency: Heterogeneity (I² statistic = 76%; Chi² statistic = 16.93; P = 0.002) is present. One trial is an outlier (<a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010767-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010767-sec-0017"></div> <section id="CD010767-sec-0018"> <h3 class="title" id="CD010767-sec-0018">Description of the condition</h3> <p>Anaemia is a public health problem that affects people worldwide. Between 1993 and 2005, an estimated 1.62 billion people worldwide had anaemia, which corresponded to 24.8% of the world's population (<a href="./references#CD010767-bbs2-0058" title="deBenoistB , McLeanE , EgliI , CogswellM (editors) . Worldwide prevalence of anaemia 1993‐2005. http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf (05/02/2013):1‐40. ">WHO 2008</a>). The reported global prevalence was 47.4% in children aged under five. Children in Africa and South‐East Asia carried the highest reported burden of anaemia: 67.6% and 65.5% respectively (<a href="./references#CD010767-bbs2-0058" title="deBenoistB , McLeanE , EgliI , CogswellM (editors) . Worldwide prevalence of anaemia 1993‐2005. http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf (05/02/2013):1‐40. ">WHO 2008</a>). Causes of anaemia are multifactorial and include poor nutritional status, micronutrient deficiencies (especially iron deficiency, but also vitamin A, vitamin B and folic acid), intestinal helminth infection, HIV infection and haemoglobinopathies (<a href="./references#CD010767-bbs2-0021" title="CalisJC , PhiriKS , FaragherEB , BrabinBJ , BatesI , CuevasLE , et al. Severe anemia in Malawian children. New England Journal of Medicine2008;358(9):888‐99. ">Calis 2008</a>). However, malaria is probably the most important cause of anaemia in malaria‐endemic countries (<a href="./references#CD010767-bbs2-0017" title="AntonyAC . Severe anemia in Malawian children. New England Journal of Medicine2008;358(21):2291; author reply 2291. ">Antony 2008</a>; <a href="./references#CD010767-bbs2-0018" title="BalarajanY , RamakrishnanU , OzaltinE , ShankarAH , SubramanianSV . Anaemia in low‐income and middle‐income countries. Lancet2011;378(9809):2123‐35. ">Balarajan 2011</a>; <a href="./references#CD010767-bbs2-0022" title="CrawleyJ . Reducing the burden of anemia in infants and young children in malaria‐endemic countries of Africa: from evidence to action. American Journal of Tropical Medicine and Hygiene2004;71(2 Suppl):25‐34. ">Crawley 2004</a>). Anaemia is also more common in children from low‐income and illiterate families, compared to children coming from wealthier households (<a href="./references#CD010767-bbs2-0018" title="BalarajanY , RamakrishnanU , OzaltinE , ShankarAH , SubramanianSV . Anaemia in low‐income and middle‐income countries. Lancet2011;378(9809):2123‐35. ">Balarajan 2011</a>). </p> <p>Malaria causes anaemia mainly by destruction of red blood cells (haemolysis) (<a href="./references#CD010767-bbs2-0039" title="LooareesuwanS , MerryAH , PhillipsRE , PleehachindaR , WattanagoonY , HoM , et al. Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. British Journal of Haematology1987;67(4):473‐8. ">Looareesuwan 1987</a>) but also by causing an increase in the splenic pool of red blood cells and decreased production of red blood cells (<a href="./references#CD010767-bbs2-0022" title="CrawleyJ . Reducing the burden of anemia in infants and young children in malaria‐endemic countries of Africa: from evidence to action. American Journal of Tropical Medicine and Hygiene2004;71(2 Suppl):25‐34. ">Crawley 2004</a>; <a href="./references#CD010767-bbs2-0046" title="PhillipsRE , PasvolG . Anaemia of Plasmodium falciparum malaria. Baillière's Clinical Haematology1992;5(2):315‐30. ">Phillips 1992</a>). Acute loss of red blood cells may lead to severe anaemia. Chronic anaemia can slow growth and result in learning difficulties and behavioural changes in affected children (<a href="./references#CD010767-bbs2-0027" title="Grantham‐McGregorS , AniC . A review of studies on the effect of iron deficiency on cognitive development in children. Journal of Nutrition2001;131(2S‐2):649S‐68S. ">Grantham‐McGregor 2001</a>; <a href="./references#CD010767-bbs2-0040" title="LozoffB , JimenezE , WolfAW . Long‐term developmental outcome of infants with iron deficiency. New England Journal of Medicine1991;325(10):687‐94. ">Lozoff 1991</a>). </p> <p>The symptoms of anaemia vary according to the severity, the age of the affected person, and whether the anaemia is acute or chronic. People with anaemia report fatigue, shortness of breath and palpitations. Clinical signs include paleness of the mucosal linings, such as the tongue, conjunctiva, palm and nail bed (<a href="./references#CD010767-bbs2-0035" title="KalterHD , BurnhamG , KolstadPR , HossainM , SchillingerJA , KhanNZ , et al. Evaluation of clinical signs to diagnose anaemia in Uganda and Bangladesh, in areas with and without malaria. Bulletin of the World Health Organization1997;75(Suppl 1):103‐11. ">Kalter 1997</a>). Although palm pallor is commonly used for classification of disease in children (<a href="./references#CD010767-bbs2-0041" title="MeremikwuM , EhiriJE . Chapter 27: Integrated management of childhood illness. Maternal and child health: global challenges, programs and policies. New York: Springer, 2009:497‐514. ">Meremikwu 2009</a>), diagnosis of anaemia is based on laboratory tests. The World Health Organization (WHO) has defined anaemia in pre‐school aged children as a haemoglobin (Hb) concentration of less than 11 g/dL (<a href="./references#CD010767-bbs2-0058" title="deBenoistB , McLeanE , EgliI , CogswellM (editors) . Worldwide prevalence of anaemia 1993‐2005. http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf (05/02/2013):1‐40. ">WHO 2008</a>) and severe anaemia, often a complication of severe malaria, as a Hb concentration of less than 5 g/dL (<a href="./references#CD010767-bbs2-0056" title="WHO , Communicable Diseases Cluster. Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 24/07/2012;94(Suppl 1):S1‐90. ">WHO 2000</a>). In a study assessing the short and long term outcome of severe anaemia in Malawian children, children hospitalized and treated for severe anaemia had a significantly higher mortality rate (in‐hospital and post‐discharge) than children who were seen in hospital for other conditions and those from the community (<a href="./references#CD010767-bbs2-0047" title="PhiriKS , CalisJCJ , FaragherB , NkhomaE , Ng'omaK , MangochiB , et al. Long term outcome of severe anaemia in Malawian children. PLoS One2008;3(8):e2903. ">Phiri 2008</a>). Furthermore, researchers estimate that severe anaemia probably accounts for more than half of all childhood deaths from malaria in Africa (<a href="./references#CD010767-bbs2-0022" title="CrawleyJ . Reducing the burden of anemia in infants and young children in malaria‐endemic countries of Africa: from evidence to action. American Journal of Tropical Medicine and Hygiene2004;71(2 Suppl):25‐34. ">Crawley 2004</a>). Children who are affected may need to be admitted to hospital and may need blood transfusions (<a href="./references#CD010767-bbs2-0043" title="ObonyoCO , VululeJ , AkhwaleWS , GrobbeeDE . In‐hospital morbidity and mortality due to severe malarial anemia in western Kenya. American Journal of Tropical Medicine and Hygiene2007;77(6 Suppl):23‐8. ">Obonyo 2007</a>). </p> <p>A Cochrane Review has shown that long lasting insecticide‐treated net (LLIN) use was highly effective in reducing childhood mortality and morbidity from malaria and had a positive effect on anaemia in children (<a href="./references#CD010767-bbs2-0038" title="LengelerC . Insecticide‐treated bed nets and curtains for preventing malaria. Cochrane Database of Systematic Reviews2009, Issue 2. [DOI: 10.1002/14651858.CD000363.pub2] ">Lengeler 2009</a>). These vector control strategies are a core component of the malaria control programmes globally and especially in Africa (<a href="./references#CD010767-bbs2-0060" title="WHO . World Malaria Report 2012. http://www.who.int/malaria/publications/world_malaria_report_2012/report/en/index.html (30/07/2013):1‐195. ">WHO 2012a</a>). Other measures to prevent anaemia include prompt and effective treatment of malaria infections, intestinal helminths and human immunodeficiency virus (HIV), increased use of measures to prevent mother‐to‐child transmission of HIV and provision of micronutrient supplementation (<a href="./references#CD010767-bbs2-0018" title="BalarajanY , RamakrishnanU , OzaltinE , ShankarAH , SubramanianSV . Anaemia in low‐income and middle‐income countries. Lancet2011;378(9809):2123‐35. ">Balarajan 2011</a>; <a href="./references#CD010767-bbs2-0022" title="CrawleyJ . Reducing the burden of anemia in infants and young children in malaria‐endemic countries of Africa: from evidence to action. American Journal of Tropical Medicine and Hygiene2004;71(2 Suppl):25‐34. ">Crawley 2004</a>). </p> </section> <section id="CD010767-sec-0019"> <h3 class="title" id="CD010767-sec-0019">Description of the intervention</h3> <p>Intermittent preventive treatment (IPT) is the administration of a full course of antimalarial treatment to a population at risk of malaria during a specific time period, regardless of whether or not they are known to be infected (<a href="./references#CD010767-bbs2-0028" title="GreenwoodB . Review: Intermittent preventive treatment ‐ a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Tropical Medicine &amp; International Health2006;11(7):983‐91. ">Greenwood 2006</a>). IPT policies were first implemented in pregnant women (IPTp) living in areas with a high rate of seasonal malaria transmission. This treatment consisted of a single dose of sulphadoxine/pyrimethamine (SP) given two or three times during the pregnancy, and was introduced as an alternative to chemoprophylaxis with chloroquine (CQ), due to the increasing CQ resistance and unpopularity of the drug (<a href="./references#CD010767-bbs2-0029" title="GreenwoodB . Anti‐malarial drugs and the prevention of malaria in the population of malaria endemic areas. Malaria Journal2010;9(Suppl 3):S2. ">Greenwood 2010</a>). The WHO also recommends that IPT in infants (IPTi) up to the age of 12 months, should be administered together with the second and third diphtheria‐pertussis‐tetanus (DPT) and measles vaccination of infants in areas that have a moderate to high transmission rate of malaria (<a href="./references#CD010767-bbs2-0059" title="WHO . WHO policy recommendation on intermittent preventive treatment during infancy with sulphadoxine‐pyrimethamine (SP‐IPTi) for Plasmodium falciparum malaria control in Africa. March 2010. http://www.who.int/malaria/news/WHO_policy_recommendation_IPTi_032010.pdf (06/11/2012):1‐3. ">WHO 2010</a>; <a href="./references#CD010767-bbs2-0060" title="WHO . World Malaria Report 2012. http://www.who.int/malaria/publications/world_malaria_report_2012/report/en/index.html (30/07/2013):1‐195. ">WHO 2012a</a>). </p> <p>IPT was first made available for children (IPTc) after it had been shown that most children in highly seasonal malaria areas suffer from malaria and its related complications during the rainy season (<a href="./references#CD010767-bbs2-0023" title="DickoA , DialloAI , TembineI , DickoY , DaraN , SidibeY , et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide‐treated bednet in Mali: a randomised, double‐blind, placebo‐controlled trial. PLoS Medicine2011;8(2):e1000407. ">Dicko 2011</a>). Two recent systematic reviews have demonstrated that IPTc reduces episodes of clinical malaria in areas with a high rate of seasonal malaria transmission (<a href="./references#CD010767-bbs2-0042" title="MeremikwuM , DoneganS , SinclairD , EsuE , OringanjeC . Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD003756.pub4] ">Meremikwu 2012</a>; <a href="./references#CD010767-bbs2-0063" title="WilsonAL , IPTcTaskforce . A systematic review and meta‐analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS One2011;6(2):e16976. ">Wilson 2011</a>). Currently, the WHO recommends seasonal malarial chemoprevention (SMC) or IPTc, in seasonal malarial areas during the transmission season (<a href="./references#CD010767-bbs2-0061" title="WHO Global Malaria Programme. WHO policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub‐region in Africa. http://www.who.int/malaria/publications/atoz/smc_policy_recommendation_en_032012.pdf (01/02/2013):1‐4. ">WHO 2012b</a>). This consists of a complete treatment course of SP and amodiaquine (AQ), given to children aged between three to 59 months, at monthly intervals, during the high risk period of malaria transmission. Children may receive up to four doses of this antimalarial treatment during the malaria transmission season with the aim of maintaining therapeutic drug levels during the period of high transmission. This strategy excludes areas with SP resistance outbreak (<a href="./references#CD010767-bbs2-0062" title="WHO . Seasonal malaria chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in children: A field guide. August 2013. http://www.who.int/malaria/publications/atoz/9789241504737/en/ (13/09/2013):1‐56. ">WHO 2013</a>). </p> </section> <section id="CD010767-sec-0020"> <h3 class="title" id="CD010767-sec-0020">How the intervention might work</h3> <p>Children with severe anaemia, for whom routine management like blood transfusions and hematinics is insufficient to improve the Hb level, might benefit from IPT, since it has been shown to augment the effect of hematinics on Hb recovery when administered together in anaemic children (<a href="./references#CD010767-bbs2-0015" title="AkechSO , HassallO , PambaA , IdroR , WilliamsTN , NewtonCR , et al. Survival and haematological recovery of children with severe malaria transfused in accordance to WHO guidelines in Kilifi, Kenya. Malaria Journal2008;7:256. ">Akech 2008</a>; <a href="./references#CD010767-bbs2-0048" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi : a multicentre, randomised, placebo‐controlled trial. Lancet Infectious Diseases2011;12(3):191‐200. ">Phiri 2011</a>; <a href="./references#CD010767-bbs2-0053" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002</a>). In addition, IPT enables hematological recovery by preventing and treating new malaria infections (<a href="./references#CD010767-bbs2-0055" title="WhiteNJ . Antimalarial drug resistance. Journal of Clinical Investigation2004;113(8):1084‐92. ">White 2004</a>). Combining the effect of IPT, LLIN, and other programs like deworming and iron supplementation might add significant benefit in reducing the burden of anaemia in pre‐school aged children. Iron supplementation is often recommended for children with anaemia, although there are concerns about an association between iron supplementation and increased malaria morbidity and mortality (<a href="./references#CD010767-bbs2-0057" title="WHO , UNICEF . Iron supplementation of young children in regions where malaria transmission is intense and infectious disease highly prevalent. http://www.who.int/nutrition/publications/micronutrients/WHOStatement_%20iron%20suppl.pdf (23/07/2012):1‐2. ">WHO 2006</a>). However, a recent Cochrane Review concluded that there is high quality evidence that iron supplementation, even when given together with antimalarial treatment, does not increase the risk of clinical malaria morbidity or mortality (<a href="./references#CD010767-bbs2-0044" title="OkebeJU , YahavD , ShbitaR , PaulM . Oral iron supplements for children in malaria‐endemic areas. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD006589.pub3] ">Okebe 2011</a>). </p> <p>A Cochrane Review reported that IPT, when given to treat malaria, also increased Hb levels of children (<a href="./references#CD010767-bbs2-0042" title="MeremikwuM , DoneganS , SinclairD , EsuE , OringanjeC . Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD003756.pub4] ">Meremikwu 2012</a>). They also concluded that there is moderate quality evidence that children given IPT were less likely to have moderately severe anaemia at follow‐up (Hb &lt; 8 g/dL) compared to placebo (Risk ratio (RR) 0.71, 95% confidence interval (CI) 0.52 to 0.98). </p> </section> <section id="CD010767-sec-0021"> <h3 class="title" id="CD010767-sec-0021">Why it is important to do this review</h3> <p>The prevalence of anaemia in pre‐school aged children remains high, especially in children living in Africa and South‐East Asia. The Cochrane Review of IPT in areas with seasonal transmission of malaria showed promising effects on preventing and treating anaemia in children (<a href="./references#CD010767-bbs2-0042" title="MeremikwuM , DoneganS , SinclairD , EsuE , OringanjeC . Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD003756.pub4] ">Meremikwu 2012</a>). Although the review included all pre‐school aged children living in malaria‐endemic regions, it did not examine the effects of IPT on children diagnosed with anaemia. </p> <p>Since the two systematic reviews on IPT for malaria (<a href="./references#CD010767-bbs2-0042" title="MeremikwuM , DoneganS , SinclairD , EsuE , OringanjeC . Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD003756.pub4] ">Meremikwu 2012</a>; <a href="./references#CD010767-bbs2-0063" title="WilsonAL , IPTcTaskforce . A systematic review and meta‐analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS One2011;6(2):e16976. ">Wilson 2011</a>) have conflicting results on the effect of IPT on anaemia, a formal assessment of existing studies in a systematic review can provide physicians, policy makers and researchers with reliable evidence on the use of IPT in anaemic children living in malaria‐endemic areas with a high seasonal transmission rate. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010767-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010767-sec-0022"></div> <p>To assess the effect of intermittent preventive antimalarial treatment for children with anaemia living in malaria‐endemic areas. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010767-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010767-sec-0023"></div> <section id="CD010767-sec-0024"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010767-sec-0025"> <h4 class="title">Types of studies</h4> <p>Randomized controlled trials (RCTs) and cluster‐RCTs.</p> </section> <section id="CD010767-sec-0026"> <h4 class="title">Types of participants</h4> <p>Children with anaemia (Hb &lt; 11 g/dL; <a href="./references#CD010767-bbs2-0058" title="deBenoistB , McLeanE , EgliI , CogswellM (editors) . Worldwide prevalence of anaemia 1993‐2005. http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf (05/02/2013):1‐40. ">WHO 2008</a>) living in malaria‐endemic areas. </p> </section> <section id="CD010767-sec-0027"> <h4 class="title">Types of interventions</h4> <section id="CD010767-sec-0028"> <h5 class="title">Intervention</h5> <p>IPT for malaria</p> </section> <section id="CD010767-sec-0029"> <h5 class="title">Control</h5> <p>No IPT for malaria</p> <p>Co‐interventions, such as hematinics or LLINs, should be identical in both intervention and control groups. </p> </section> </section> <section id="CD010767-sec-0030"> <h4 class="title">Types of outcome measures</h4> <section id="CD010767-sec-0031"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010767-list-0001"> <li> <p>All‐cause mortality and hospital admission</p> </li> </ul> </p> </section> <section id="CD010767-sec-0032"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010767-list-0002"> <li> <p>Anaemia at follow‐up (Hb &lt; 11g/dL)</p> </li> <li> <p>Mean change in Hb (g/dL) from baseline to follow‐up</p> </li> <li> <p>Mean Hb at follow‐up (g/dL)</p> </li> </ul> </p> </section> </section> </section> <section id="CD010767-sec-0033"> <h3 class="title">Search methods for identification of studies</h3> <p>We attempted to identify all relevant studies regardless of the language and publication status (published, unpublished, in press and ongoing). </p> <section id="CD010767-sec-0034"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases up to 4 December 2014 using the search terms and strategy described in <a href="./appendices#CD010767-sec-0097">Appendix 1</a>: Cochrane Infectious Diseases Group Specialized Register, Cochrane Central of Controlled Trials (CENTRAL), published in <i>The Cochrane Library</i> (2014, Issue 11); MEDLINE; EMBASE; and LILACS. We also searched the WHO International Clinical Trial Registry Platform and metaRegister of Controlled Trials (mRCT) for ongoing trials using "anaemia", "children", "intermittent preventive treatment" and "malaria" as search terms. </p> </section> <section id="CD010767-sec-0035"> <h4 class="title">Searching other resources</h4> <section id="CD010767-sec-0036"> <h5 class="title">Reference lists</h5> <p>We checked the reference lists of all included studies for relevant trials.</p> </section> </section> </section> <section id="CD010767-sec-0037"> <h3 class="title" id="CD010767-sec-0037">Data collection and analysis</h3> <section id="CD010767-sec-0038"> <h4 class="title">Selection of studies</h4> <p>Two review authors (MA and AR) independently screened the results of the literature search for potentially eligible trials. We retrieved the full text articles of relevant studies and independently assessed eligibility using an eligibility form. We contacted trial authors in cases of missing or unclear information. We resolved discrepancies through discussion or alternatively through consulting the third review author, AMK. We ensured that multiple publications of the same trial were only included once. We listed excluded studies, together with the reasons for exclusion, in table format. </p> </section> <section id="CD010767-sec-0039"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (MA and AR) extracted data independently using pre‐piloted, electronic data extraction forms. We resolved any disagreements through discussion. We contacted the trial authors in case of missing data. </p> <p>For each included trial, we extracted data on the trial design, participants, intervention, control intervention, outcomes (included outcomes, measurement of outcomes) and results. For RCTs, we extracted the number of participants randomized to each treatment arm and the number of participants monitored for each outcome of interest. For dichotomous data, we extracted the number of events in each of the treatment arms. For continuous data, we extracted the arithmetic mean, standard deviations (SDs) and the number of participants in each group. We reported the measure of effect for each outcome, RRs or mean differences, with 95% CIs. </p> </section> <section id="CD010767-sec-0040"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (MA and AR) independently assessed risk of bias for each included trial by using the Cochrane Collaboration's 'Risk of bias' assessment tool (<a href="./references#CD010767-bbs2-0032" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). All discrepancies were resolved through discussion or consultation with AMK. </p> <p>We classified risk of bias judgements as either low, high or unclear risk of bias. We assessed the following components for risk of bias in each included trial as follows: </p> <section id="CD010767-sec-0041"> <h5 class="title">Sequence generation</h5> <p>We regarded a trial as having: low risk of bias if the sequence generation was truly random (for example, computer‐generated table of random numbers, tossing a coin); high risk of bias if sequence generation contained a non‐random component (for example, alternate randomization, randomization by birth date); or unclear risk of bias if the trial authors did not clearly describe the randomization process. </p> </section> <section id="CD010767-sec-0042"> <h5 class="title">Allocation concealment</h5> <p>We regarded trials as having: low risk of selection bias if allocation was truly concealed (for example, central allocation of participants, use of sequentially numbered, opaque, sealed envelopes); high risk of bias if the allocation process was not concealed (for example, open randomization, unsealed or non‐opaque envelopes); or unclear risk of bias if the trial authors did not describe the process of allocation concealment in sufficient detail. </p> </section> <section id="CD010767-sec-0043"> <h5 class="title">Blinding of participants and personnel</h5> <p>We determined whether blinding was present, who was blinded and the methods used to blind trial participants and personnel. We regarded a trial as having: low risk of bias if blinding was present, or if the absence of blinding was unlikely to affect the outcomes; high risk of bias if blinding was absent and likely to affect the results; or at unclear risk of bias if blinding was not clearly described. </p> </section> <section id="CD010767-sec-0044"> <h5 class="title">Blinding of outcome assessors</h5> <p>We described whether blinding of outcome assessors was present and how they were blinded. We regarded a trial as having: low risk of detection bias if they were blind to knowledge about which intervention the participants received; high risk of bias if blinding was absent; and unclear risk if blinding was not clearly described. </p> </section> <section id="CD010767-sec-0045"> <h5 class="title">Incomplete outcome data</h5> <p>We regarded trials as having: low risk of attrition bias if there was no missing data or if missing data was balanced across groups and attrition rates were less that 20%; high risk of bias if there was missing data (attrition rate higher than 20%) or if missing data was more prevalent in one of the groups; or unclear risk of bias if trial authors did not clearly state whether outcome data was missing. </p> </section> <section id="CD010767-sec-0046"> <h5 class="title">Selective outcome reporting</h5> <p>We regarded a trial as having low risk of reporting bias if it was evident that all pre‐specified outcomes were reported on; high risk of bias if it was evident that not all pre‐specified outcomes were reported on; or unclear risk of bias if it was unclear whether all outcomes have been reported on. </p> </section> <section id="CD010767-sec-0047"> <h5 class="title">Other bias</h5> <p>We described any important feature of included trials that could have affected the result. </p> </section> </section> <section id="CD010767-sec-0048"> <h4 class="title">Measures of treatment effect</h4> <p>We compared dichotomous data using RRs. For continuous data summarized by arithmetic means and SDs, we presented mean difference values. We presented all results with their associated 95% CIs. </p> </section> <section id="CD010767-sec-0049"> <h4 class="title">Unit of analysis issues</h4> <p>We included two trials with a two‐by‐two factorial trial design, that is containing four treatment groups (IPT plus iron; iron only; IPT only; placebo). We included all four groups in the meta‐analyses, by making use of subgroups (IPT plus iron versus IPT without iron). </p> </section> <section id="CD010767-sec-0050"> <h4 class="title">Dealing with missing data</h4> <p>We applied available case analysis to continuous outcomes and only included data on the known results. The denominator was the total number of participants who had data recorded for the specific outcome. </p> <p>For dichotomous outcomes, we performed analyses on an intention‐to‐treat basis. We included all participants randomized to each group in the analyses and analysed participants in the group to which they were randomized. </p> <p>We calculated missing SDs from 95% CIs, if available. Where 95% CIs were not reported with the mean Hb level at follow‐up, we borrowed the SDs reported for the mean Hb levels at baseline (<a href="./references#CD010767-bbs2-0032" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Where mean values were not reported for the outcome (mean change in Hb from baseline to follow‐up) we calculated means by subtracting the mean value at baseline from the mean value at follow‐up. We imputed the corresponding SD by calculating a correlation coefficient from a reported mean and SD (mean change in Hb from baseline to follow‐up) in <a href="./references#CD010767-bbs2-0013" title="RohnerF , ZimmermannMB , AmonRJ , VounatsouP , TschannenAB , N'GoranEK , et al. In a randomized controlled trial of iron fortification, anthelmintic treatment, and intermittent preventive treatment of malaria for anemia control in Ivorian children, only anthelmintic treatment shows modest benefit. Journal of Nutrition2010;140(3):635–41. ">Rohner 2010</a>, after consultation with a statistician. This study examined the effect of IPT on malaria and anaemia in children, but included both anaemic and non‐anaemic children and thus we excluded it from this review. </p> </section> <section id="CD010767-sec-0051"> <h4 class="title">Assessment of heterogeneity</h4> <p>We inspected forest plots for overlapping CIs and assessed statistical heterogeneity in each meta‐analysis using the I² and Chi² statistics. We regarded heterogeneity as moderate if I² statistic values were between 30% and 60%; substantial if they were between 50% and 90%; and considerable if they were between 75% and 100%. We regarded a P value of 0.10 or less indicative of statistically significant heterogeneity. </p> </section> <section id="CD010767-sec-0052"> <h4 class="title">Assessment of reporting biases</h4> <p>We did not formally assess reporting biases, since we only included six trials in the review. </p> </section> <section id="CD010767-sec-0053"> <h4 class="title">Data synthesis</h4> <p>We used <a href="./references#CD010767-bbs2-0049" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a> for data analysis. If considerable heterogeneity was present, we combined data using random‐effects meta‐analysis and reported an average treatment effect, since this was considered to be clinically meaningful. We presented results using forest plots. </p> <section id="CD010767-sec-0054"> <h5 class="title">Evidence quality</h5> <p>We assessed the quality of evidence using the GRADE approach (<a href="./references#CD010767-bbs2-0030" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction ‐ GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. ">Guyatt 2011</a>). We rated each outcome as either high (we are very confident that the true effect lies close to that of the estimate of the effect); moderate (we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect); low (our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect); or very low quality of evidence (we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect) (<a href="./references#CD010767-bbs2-0019" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401‐6. ">Balshem 2011</a>). </p> <p>RCTs are regarded as high quality evidence but can be downgraded within the following five categories: study limitations, imprecision, inconsistency, indirectness and publication bias. Studies can also be upgraded if there is a large effect, a dose‐response effect, or if all plausible residual confounding would reduce a demonstrated effect or would suggest a spurious effect if no effect was observed (<a href="./references#CD010767-bbs2-0019" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401‐6. ">Balshem 2011</a>). We summarized our findings in a 'Summary of findings' table. </p> </section> </section> <section id="CD010767-sec-0055"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed the following subgroup analyses:</p> <p> <ul id="CD010767-list-0003"> <li> <p>Additional interventions to treat anaemia (such as hematinics or folic acid)</p> </li> <li> <p>Hospital recruitment versus community recruitment</p> </li> </ul> </p> <p>We performed subgroup analyses for the following outcomes:</p> <p> <ul id="CD010767-list-0004"> <li> <p>All‐cause mortality and hospital admissions at six months follow‐up</p> </li> <li> <p>Anaemia at 12 weeks follow‐up</p> </li> <li> <p>Mean change in Hb from baseline to follow‐up (12 weeks)</p> </li> <li> <p>Mean Hb at follow‐up (12 weeks)</p> </li> </ul> </p> <p>We assessed differences between subgroups using the Chi<sup>2</sup> test with a P value of 0.05 or less indicating statistically significant differences between subgroups. </p> <p>We documented the drugs used for IPT in the footnotes for each forest plot. There was no evidence of heterogeneity by drug type, which might be anticipated with emerging sulfadoxine‐pyrimethamine (SP) resistance, so we did not subgroup by drug type. </p> </section> <section id="CD010767-sec-0056"> <h4 class="title">Sensitivity analysis</h4> <p>Due to the limited amount of included trials, we did not perform sensitivity analysis.</p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010767-sec-0057" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010767-sec-0057"></div> <section id="CD010767-sec-0058"> <h3 class="title">Description of studies</h3> <p>See <a href="#CD010767-tbl-0002">Table 1</a>; <a href="./references#CD010767-sec-0105" title="">Characteristics of included studies</a>; <a href="./references#CD010767-sec-0106" title="">Characteristics of excluded studies</a>. </p> <div class="table" id="CD010767-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of trial characteristics</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sample size (n randomized)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1200</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>554</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1431</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>328</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>238</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Country</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The Gambia (Banjul)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The Gambia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenya (Western Kenya)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Malawi (southern Malawi)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenya (Eastern province)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tanzania (Kigoma region)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endemicity</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>low*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>low*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>high*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>high*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>low*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>moderate/high (50% parasitaemia)**</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Age</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months to 9 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 to 72 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 to 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 59 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 to 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 to 59 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Anaemia</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb 69 to 110 g/L</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb 7.0 to 10.9 g/dL</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All children treated for severe malarial anaemia with transfusion and completed the course of intravenous quinine with subsequent Hb &gt; 5g/dL </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb 60 to 110 g/L</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb 5.0 to 8.0 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Malaria</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not criteria for inclusion. Children with malaria were treated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncomplicated malaria</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No malaria (aparasitaemic) or parasite counts &lt; 20,000 parasites/mm<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No clinical malaria</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not described as part of eligibility</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Recruitment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital or OPD admission</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Active and passive case finding of children in community</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community: resident children screened</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital admissions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community: randomly selected</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health care worker diagnosed children with clinical anaemia and referred them to the trial </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Trial intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD010767-list-0005"> <li> <p>IPT (SP)</p> </li> <li> <p>Placebo</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD010767-list-0006"> <li> <p>IPT (CQ)</p> </li> <li> <p>Placebo</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD010767-list-0007"> <li> <p>IPT (SP) + iron</p> </li> <li> <p>IPT (SP) + iron placebo</p> </li> <li> <p>Iron + IPT placebo</p> </li> <li> <p>Iron placebo + IPT placebo</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD010767-list-0008"> <li> <p>IPT(post discharge): AL</p> </li> <li> <p>Placebo</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD010767-list-0009"> <li> <p>IPT (SP) + iron</p> </li> <li> <p>IPT (SP) + iron placebo</p> </li> <li> <p>Iron + IPT placebo</p> </li> <li> <p>Iron placebo + IPT placebo</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD010767-list-0010"> <li> <p>Vitamin placebo 3X per week</p> </li> <li> <p>Vitamin placebo + IPT (SP)</p> </li> <li> <p>VAC + IPT (SP)</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Iron and other supplementation during trial period (all participants)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: oral iron for 28 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No ‐ part of trial intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No – part of trial intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: Iron and folic acid for 12 weeks</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Baseline treatment for all participants</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some were treated with quinine and SP or CQ and SP. Not all children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Either CQ and SP or AL</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single dose of SP</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 day course of AL<br/> in hospital (6 doses) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single dose of SP; mebendazole for participants &gt; 12 months</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*endemicity derived from the Malaria Atlas Project (<a href="./references#CD010767-bbs2-0025" title="GethingPW , PatilAP , SmithDL , GuerraCA , ElyazarIRF , JohnstonGL , et al. A new world malaria map: Plasmodium falciparum endemicity in 2010. Malaria Journal2011;10:378. ">Gething 2011</a>). </p> <p>**as reported in the trial (<a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>). </p> <p>Abbreviations:</p> <p>Hb: Haemoglobin</p> <p>OPD: Out patient department</p> <p>IPT: Intermittent preventive treatment</p> <p>SP:Sulfadoxine‐pyrimethamine</p> <p>CQ: Chloroquine</p> <p>AL: Arthemeter‐lumefantrine</p> <p>VAC: Vitamin A and C</p> </div> </div> <section id="CD010767-sec-0059"> <h4 class="title">Results of the search</h4> <p>Our search yielded 88 records. We excluded 74 studies after screening abstracts and a further eight studies after assessing eligibility of full texts. We included six RCTs (3847 participants). See <a href="#CD010767-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD010767-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010767-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010767-sec-0060"> <h4 class="title">Included studies</h4> <section id="CD010767-sec-0061"> <h5 class="title">Trial designs</h5> <p>All included trials were individually RCTs. Two trials with a factorial design (<a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>; <a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a>) had four trial arms. One trial had three arms (<a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>) and the remaining three trials had two trial arms. Most of the included RCTs had an intervention period of approximately 12 weeks, at which time outcomes were assessed, and some trials had an extended follow‐up period of up to one year post enrolment. </p> </section> <section id="CD010767-sec-0062"> <h5 class="title">Location</h5> <p>All included trials were conducted in malaria‐endemic areas. Three trials were conducted in low endemicity areas: two in The Gambia (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>) and one in eastern Kenya (<a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a>). Three trials were conducted in high endemicity areas: one in western Kenya (<a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>), one in southern Malawi (<a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a>) and one in western Tanzania (<a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>). </p> </section> <section id="CD010767-sec-0063"> <h5 class="title">Participants</h5> <p>The age of the anaemic children ranged between two months and nine years. In five trials, children had mild to moderate anaemia (Hb 5 to 11 g/dL) at enrolment. The remaining trial enrolled children with Hb levels less than 7 g/dL (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>). In one trial, children had severe malaria (<a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a>), two trials included children with uncomplicated malaria (<a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>; <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>), for two trials malaria was not part of the inclusion criteria (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>) and one trial excluded children with clinical malaria (<a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a>). Three trials (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a>; <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>) recruited children that attended outpatient clinics or were admitted to hospital, while three trials recruited children from the community (<a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>; <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>; <a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a>). </p> </section> <section id="CD010767-sec-0064"> <h5 class="title">Interventions</h5> <section id="CD010767-sec-0065"> <h6 class="title">Baseline treatments</h6> <p>In four trials, children in intervention and placebo groups received baseline treatment for malaria or anaemia. In two of these trials, all children were given a single dose of SP (<a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>; <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>). In one trial (<a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>) children received either CQ and SP or artemether‐lumefantrine (AL) before randomization to intervention and placebo groups. <a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a> treated all children with intravenous quinine and blood transfusion while in hospital and AL at discharge. In addition, <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a> administered a single dose of mebendazole to all children over the age of 12 months. </p> <p>In <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> only children with malaria were treated with quinine and SP or CQ and SP. <a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a> was the only trial where no baseline treatment was given to children. </p> </section> <section id="CD010767-sec-0066"> <h6 class="title">Trial interventions</h6> <p>All included RCTs compared IPT to placebo. The types of IPT used were the following:</p> <p> <ul id="CD010767-list-0011"> <li> <p>SP (500 mg sulfadoxine/25 mg pyrimethamine per tablet, given at an approximate dose of 25 mg sulfadoxine/1.25 mg pyrimethamine per kg) given monthly for an average of 12 weeks or until the end of the malaria transmission period (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>; <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>; <a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a>). A drug sensitivity study of SP in a multicentre trial in Eastern Kenya and Kigoma Tanzania (<a href="./references#CD010767-bbs2-0026" title="GorissenE , AshrufG , LambooM , BennebroekJ , GikundaS , MbarukuG , et al. In vivo efficacy study of amodiaquine and sulfadoxine/pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania. Tropical Medicine &amp; International Health2000;5(6):459‐63. ">Gorissen 2000</a>) between 1998 and 2000 showed efficacy of more than 85%. However, these findings differed from other studies done in East Africa, which reported on resistance of <i>Plasmodium falciparum</i> to SP between 1995 and 1997. This finding did not have a strong association with the clinical evidence (<a href="./references#CD010767-bbs2-0033" title="JelinekT , RønnAM , CurtisJ , DuraisinghMT , LemngeMM , MhinaJ , et al. High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance. Tropical Medicine &amp; International Health1997;2(11):1075‐9. ">Jelinek 1997</a>; <a href="./references#CD010767-bbs2-0052" title="TerlouwDJ , NahlenBL , CourvalJM , KariukiSK , RosenbergOS , OlooAJ , et al. Sulfadoxine‐pyrimethamine in treatment of malaria in Western Kenya: increasing resistance and underdosing. Antimicrobial Agents and Chemotherapy2003;47(9):2929‐32. ">Terlouw 2003</a>). In contrast to East Africa, reports on declining SP efficacy and its resistance on <i>P. falciparum</i> were already reported by several studies in The Gambia by 1998 (<a href="./references#CD010767-bbs2-0024" title="DunyoS , OrdR , HallettR , JawaraM , WalravenG , MesaE , et al. Randomised trial of chloroquine/sulphadoxine‐pyrimethamine in Gambian children with malaria: impact against multidrug‐resistant P. falciparum . PLoS Clinical Trials2006;1(3):e14. ">Dunyo 2006</a>; <a href="./references#CD010767-bbs2-0054" title="vonSeidleinL , MilliganP , PinderM , BojangK , AnyalebechiC , GoslingR , et al. Efficacy of artesunate plus pyrimethamine‐sulphadoxine for uncomplicated malaria in Gambian children: a double‐blind, randomised, controlled trial. Lancet2000;355(9201):352‐7. ">von Seidlein 2000</a>). </p> </li> <li> <p>AL tablets (20 mg artemether, 120 mg lumefantrine per tablet, children weighing 15 kg or more received two tablets, less than 15 kg received one tablet) given as a three day course (six doses) monthly for 12 weeks (<a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a>). Artemisinin combination therapies (ACTs) were adopted in most African countries after 2005. In Malawi, an earlier study (2004 to 2006) had already shown efficacy of above 85% (<a href="./references#CD010767-bbs2-0020" title="BellDJ , WoottonD , MukakaM , MontgomeryJ , KayangeN , ChimpeniP , et al. Measurement of adherence, drug concentrations and the effectiveness of artemether‐lumefantrine, chlorproguanil‐dapsone or sulphadoxine‐pyrimethamine in the treatment of uncomplicated malaria in Malawi. Malaria Journal2009;8:204. ">Bell 2009</a>). This finding was supported by another study in the same country which found less genetic amplification of <i>P. falciparum</i> to Coartem (<a href="./references#CD010767-bbs2-0031" title="HaildarK , MohandasN . Malaria,erthrocytic infection and anaemia. Hematology Am. Soc Hematol Educ Program2009;10(1):87‐93. ">Haildar 2009</a>). </p> </li> <li> <p>CQ syrup (5 mg/kg) given as a weekly dose (three day course) for 12 weeks (<a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>). CQ sensitivity studies conducted in the early 2000s in The Gambia and Mali revealed low efficacy of CQ (<a href="./references#CD010767-bbs2-0051" title="TeketeM , DjimdeAA , BeavoguiAH , MaigaH , SagaraI , FofanaB , et al. Efficacy of chloroquine, amodiaquine and sulphadoxine‐pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali. Malaria Journal2009;8:34. ">Tekete 2009</a>) with evidence of increased resistance of CQ to <i>P. falciparum</i> (<a href="./references#CD010767-bbs2-0045" title="OrdR , AlexanderN , DunyoS , HallettR , JawaraM , TargettG , et al. Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine‐resistant parasites. Journal of Infectious Diseases2007;196(11):1613‐9. ">Ord 2007</a>). </p> </li> </ul> </p> <p>Four trials gave iron as part of the intervention. In two trials, all children received iron, regardless of whether they were in the intervention or placebo group (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>). <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> administered iron for 28 days and <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a> gave iron and folic acid for 12 weeks. In the two‐by‐two factorial trials (<a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>; <a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a>), children were randomized to receive either iron or placebo. </p> <p>In addition, children in one of the three intervention groups in <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a> received vitamin A and C (VAC) three times a week. </p> </section> <section id="CD010767-sec-0067"> <h6 class="title">Co‐interventions</h6> <p>Two trials did not report the use of LLINs (<a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>; <a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a>). In <a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>, LLIN distribution was part of the standard malaria prevention programme and in <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a> all households were issued with LLINs, but both studies did not assess the use of LLINs. <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> assessed LLIN use at the end of the transmission period (20.7% in IPT group; 15.3% in placebo) and the reported bed net use in <a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a> was similar in both groups, overall use was 51% (35% treated net, 16% untreated net). </p> </section> </section> <section id="CD010767-sec-0068"> <h5 class="title">Outcomes</h5> <p>Trials reported on a variety of outcomes (<a href="#CD010767-tbl-0003">Table 2</a>). </p> <div class="table" id="CD010767-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of outcomes reported in trials</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Outcomes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Trial</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b> Haematological outcomes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Mean Hb at end of follow‐up</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean Hb level at end of transmission period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb concentration (measured in g/dL)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb concentration at the end of follow‐up (12 weeks)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean Hb</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Mean change of Hb from baseline to follow‐up </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean change of Hb from baseline to follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Children with anaemia at follow‐up </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children with moderate or severe anaemia at the end of the transmission period* </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hematological recovery (Hb ≥ 11g/dL before or at week 12)</p> <p>Severe anaemia (Hb &lt; 7 g/dL before or at week 12)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anaemia (Hb &lt; 11.0 g/dL)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prevalence of anaemia (Hb &lt; 11.0 g/dL)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Other</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in erythropoietic response</p> <p>Hb change from baseline to follow‐up in two placebo arms to investigate the effect of antimalarial therapy </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MCV (measured in fL)</p> <p>sTfR concentration (measured in µg/mL)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iron deficiency (serum ferritin concentration &lt; 12 µg/L)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean TfR level</p> <p>Prevalence of iron deficiency (TfR &lt; 8.5 µg/mL)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b> Malaria outcomes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Clinical malaria</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical episodes of malaria during the surveillance period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical malaria (axillary temperature 37.5 with co‐existing malaria parasitaemia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children with at least one malaria attack (defined as presence of fever, that is temperature ≥ 37.5°C, and a positive dipstick result)* </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Malaria parasitaemia</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prevalence of parasitaemia and splenomegaly</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prevalence of submicroscopic malaria parasitaemia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prevalence of malaria parasitaemia</p> <p>Parasite density (parasites/mm<sup>3</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Hospital admissions or clinic visits related to malaria</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital re‐admission because of all‐cause severe anaemia or severe malaria</p> <p>Clinic visits because of microscopically confirmed non‐severe malaria</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Other</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to first occurrence of malaria attack</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> All‐cause mortality and hospital admission </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Composite outcome of all‐cause mortality and hospital readmission because of all‐cause severe anaemia or severe malaria between 1 and 6 months* </p> <p>All‐cause hospital admission</p> <p>All‐cause mortality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Visits to healthcare facilities</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient attendance</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinic visits (incidence, number of episodes)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause sick child clinic visits</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Other</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nutritional status at the end oft he transmission period</p> <p>Compliance with treatment regimen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in urinary neopterin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse drug reactions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*indicates primary outcomes</p> <p>Abbreviations:</p> <p>Hb: haemoglobin</p> <p>TfR: transferrin receptor</p> </div> </div> <section id="CD010767-sec-0069"> <h6 class="title">Haematological outcomes</h6> <p>Four trials reported on the mean Hb concentration at 12 weeks follow‐up or at the end of the transmission period. Only one trial (<a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>) reported on the mean change in Hb concentration from baseline to follow‐up. </p> <p>Four trials reported on the number of children with anaemia at 12 weeks or at the end of the transmission period. Anaemia was defined as Hb &lt; 11 g/dL in three trials (<a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>; <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>; <a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a>). <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> reported the number of children with an Hb &lt; 7 g/dL and <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a> reported the outcome separately for children with an Hb &lt; 11 g/dL and those with Hb &lt; 7 g/dL. </p> <p>Other reported outcomes included mean corpuscular volume (MCV) at 12 week follow‐up (<a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>), serum transferrin receptor (TfR) concentration at 12 weeks follow‐up (<a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>; <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>), iron deficiency measured as serum ferritin &lt; 12 µg/L in <a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a> and as TfR &lt; 8.5 µg/mL in <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a> and change in erythropoietic response (<a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>). </p> </section> <section id="CD010767-sec-0070"> <h6 class="title">All‐cause mortality and hospital admissions</h6> <p>All‐cause mortality plus hospital readmissions due to severe anaemia (Hb &lt; 5 g/dL or clinical indication for blood transfusion) or severe malaria (re‐admittance due to confirmed malaria treated with parenteral quinine) at three and six months was the primary outcome in <a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a>. All‐cause mortality and hospital readmission because of all‐cause severe anaemia or severe malaria were also reported on separately. </p> </section> <section id="CD010767-sec-0071"> <h6 class="title">Malaria outcomes</h6> <p>Three trials reported clinical malaria. One trial (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>) did not define clinical malaria. <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a> defined clinical malaria as an axillary temperature of 37.5°C or higher with co‐existing malaria parasitaemia. <a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a> reported the proportion of children with at least one malaria attack, defined as a temperature of 37.5°C or higher and a positive dipstick result. </p> <p>Two trials reported malaria parasitaemia (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>). <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a> also reported parasite densities. <a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a> reported on the prevalence of submicroscopic parasitaemia (detection of parasites' DNA). </p> <p><a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a> reported on clinic visits due to microscopically confirmed non‐severe malaria and <a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a> on the time to first occurrence of malaria attack. </p> </section> <section id="CD010767-sec-0072"> <h6 class="title">Other outcomes</h6> <p>Three trials reported visits to healthcare facilities (outpatients, clinics, pharmacies) (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>; <a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a>). Other outcomes reported across trials included nutritional status at the end of the transmission period, compliance with treatment regime (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>), adverse drug reactions (<a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a>) and change in urinary neopterin (<a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>). </p> </section> </section> </section> <section id="CD010767-sec-0073"> <h4 class="title">Excluded studies</h4> <p>We excluded eight trials (see <a href="./references#CD010767-sec-0106" title="">Characteristics of excluded studies</a>). Five of these did not include only anaemic children, one did not have a control group, another trial was a sub‐analysis of an included trial and the intervention of one study was chemoprophylaxis and not IPT. </p> </section> </section> <section id="CD010767-sec-0074"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall, risk of bias in included trials was low (see <a href="#CD010767-fig-0002">Figure 2</a> and <a href="#CD010767-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD010767-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials." data-id="CD010767-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials. </p> </div> </div> </div> <div class="figure" id="CD010767-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial." data-id="CD010767-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial. </p> </div> </div> </div> <section id="CD010767-sec-0075"> <h4 class="title">Allocation</h4> <p>All trials used adequate methods to generate a random sequence.</p> <p>Three RCTs (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>; <a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a>) had adequate allocation concealment. The remaining three trials had insufficient information to make a judgement about risk of bias and were thus judged as having unclear risk of bias. </p> </section> <section id="CD010767-sec-0076"> <h4 class="title">Blinding</h4> <p>Five RCTs were at low risk of performance bias and adequately blinded participants and personnel. We judged one trial (<a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>) to have high risk of bias, since one of the groups did not receive IPT placebo and the personnel had access to lists of group assignment. </p> <p>All included trials were at low risk of detection bias and adequately blinded outcome assessors. </p> </section> <section id="CD010767-sec-0077"> <h4 class="title">Incomplete outcome data</h4> <p>Two trials had high risk of attrition bias. <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> had a high rate of loss to follow‐up at the end of the transmission period, 23% (136/600) in the intervention group and 21.5% (127/600) in the placebo group. Although the overall loss to follow‐up rate in <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a> was not high, there was a significant difference in loss to follow‐up at 12 weeks between the placebo group and the other intervention groups: 4% (6/135) in the IPT + iron group; 8.6% (12/139) in the iron group; 6.6% (9/136) in the IPT group, and 20.5% (28/136) in the double placebo group. Follow‐up data at 24 weeks follow‐up was missing. </p> <p>For <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a> there was also a difference in children lost to follow‐up. In the placebo group, the loss to follow‐up was 6% (5/82), in the IPT group it was 10% (8/81) and in the IPT + VAC group it was 13% (10/75). Reasons for missing children were not stratified according to groups and we judged the risk of bias to be unclear. </p> <p>The other three trials had low risk of attrition bias.</p> </section> <section id="CD010767-sec-0078"> <h4 class="title">Selective reporting</h4> <p><a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a> did not report on the primary outcome (mean Hb concentration at follow‐up) and was therefore at high risk of reporting bias. One trial (<a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>) did not pre‐specify their outcomes in the methods section and we therefore judged risk of bias to be unclear. The remaining three RCTs had low risk of reporting bias. </p> </section> <section id="CD010767-sec-0079"> <h4 class="title">Other potential sources of bias</h4> <p>We did not identify any other sources of bias in the six included trials.</p> </section> </section> <section id="CD010767-sec-0080"> <h3 class="title" id="CD010767-sec-0080">Effects of interventions</h3> <p>See: <a href="./full#CD010767-tbl-0001"><b>Summary of findings for the main comparison</b> Summary of findings table 1</a> </p> <section id="CD010767-sec-0081"> <h4 class="title">All‐cause mortality and hospital admissions at six months</h4> <p>We included three trials (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>; <a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a>) with a total of 3160 children in the fixed‐effects meta‐analysis (<a href="./references#CD010767-fig-0004" title="">Analysis 1.1</a>). Results for all‐cause mortality and hospital admissions were included for two trials (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a>). <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> assessed outcomes at the end of the malaria transmission period and at the end of the following dry season. We included results from the dry season follow‐up for this outcome. For <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>, we only included mortality data since the hospital admissions were not reported. We extracted mortality data from the study flow‐chart. </p> <p>IPT did not reduce the risk of death or hospital admission compared to placebo (three trials, 3160 participants; <a href="./references#CD010767-fig-0004" title="">Analysis 1.1</a>; I² = 22%). Subgroup analysis did not show a significant difference between children receiving iron and children receiving no iron (Chi² = 0.09, P = 0.76, I² = 0%). There was heterogeneity in the subgroup that received iron (Chi² = 2.53, P = 0.11, I² = 61%), but this subgroup included only two trials and random‐effects meta‐analysis did not change the overall effect (RR 0.89, 95% CI 0.61 to 1.31). </p> <p>There was no significant difference between subgroups for areas with high endemicity versus areas with low endemicity (Chi² = 0.23, P = 0.63, I² = 0%; <a href="./references#CD010767-fig-0008" title="">Analysis 2.1</a>). </p> <p>Subgroup analysis further stratifying subgroups according to recruitment (hospital admission versus selected from community) did not show a difference between groups and we thus combined hospital admissions and community recruitments in the main analyses. </p> </section> <section id="CD010767-sec-0082"> <h4 class="title">Children with anaemia at 12 weeks</h4> <p>We included four RCTs (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>; <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>; <a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a>) with a total of 2237 children in the fixed‐effects meta‐analysis (<a href="./references#CD010767-fig-0005" title="">Analysis 1.2</a>). <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> assessed outcomes at the end of the malaria transmission period, therefore length of follow‐up depended on time of enrolment. </p> <p>Overall, IPT did not have an effect on the risk of anaemia compared to placebo (four trials, 2237 participants, <a href="./references#CD010767-fig-0005" title="">Analysis 1.2</a>; I² = 29%). </p> <p>Overall the heterogeneity was not remarkable in the meta‐analysis, but there was some suggestion that the subgroup with iron and the subgroup without iron were slightly different (test for subgroup difference: (Chi² = 4.74, P = 0.03, I² = 78.9%). However, the point estimate and CIs between those receiving iron and those not receiving iron was similar, and the subgroup analysis was underpowered to be confident of any conclusion (<a href="./references#CD010767-fig-0005" title="">Analysis 1.2</a>). </p> <p>There was no significant difference between subgroups for areas with high endemicity versus areas with low endemicity (Chi² = 1.43, P = 0.23, <a href="./references#CD010767-fig-0009" title="">Analysis 2.2</a>; I² = 30.2%). </p> <p>Subgroup analysis further stratifying subgroups according to recruitment (hospital admission versus selected from community) did not show a difference between groups and we thus combined hospital admissions and community recruitments in the main analyses. </p> <p>We did not include one intervention arm of <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>, where children received SP plus VAC, in the meta‐analysis. The risk for anaemia was not significantly different in these children compared to those that only received SP and vitamin placebo (one trial, 138 participants, <a href="./references#CD010767-fig-0012" title="">Analysis 3.1</a>). </p> </section> <section id="CD010767-sec-0083"> <h4 class="title">Mean change in Hb (baseline to 12 weeks)</h4> <p>We included four trials (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>; <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>; <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>) with a total of 1672 children in the fixed effects‐meta‐analysis (<a href="./references#CD010767-fig-0006" title="">Analysis 1.3</a>). Only one trial (<a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>) reported on this outcome and we calculated the values for the other four trials. <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> assessed outcomes at the end of the malaria transmission period, therefore length of follow‐up depended on time of enrolment. </p> <p>Overall, the mean change in Hb concentration from baseline to follow‐up was 0.32 g/dL higher in the IPT group compared to the placebo group (Mean difference (MD) 0.32, 95% CI 0.19 to 0.45; four trials, 1672 participants; <a href="./references#CD010767-fig-0006" title="">Analysis 1.3</a>; I² = 18%) </p> <p>Subgroup analysis did not show a difference between children receiving iron and children receiving no iron (Chi² = 0.25, P = 0.62, I² = 0%). </p> <p>There was also no significant difference between subgroups for areas with high endemicity versus areas with low endemicity (Chi² = 0.17, P = 0.68, I² = 0%; <a href="./references#CD010767-fig-0010" title="">Analysis 2.3</a>). </p> <p>Subgroup analysis further stratifying subgroups according to recruitment (hospital admission versus selected from community) did not show a difference between groups and we thus combined hospital admissions and community recruitments in the main analyses. </p> <p>We did not include one intervention arm of <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>, where children received SP plus VAC, in the meta‐analysis. The mean change in Hb from baseline to follow‐up in these children was not different from the mean change in Hb in children that only received SP (MD 0.00, 95%CI ‐0.48 to 0.48; one trial, 138 participants, <a href="./references#CD010767-fig-0013" title="">Analysis 3.2</a>). </p> </section> <section id="CD010767-sec-0084"> <h4 class="title">Mean Hb at 12 weeks</h4> <p>We included four trials (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>; <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>; <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>) with a total of 1672 children in the random‐effects meta‐analysis (<a href="./references#CD010767-fig-0007" title="">Analysis 1.4</a>). <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> assessed outcomes at the end of the malaria transmission period, therefore length of follow‐up depended on time of enrolment. <a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a> did not report on this outcome, but we calculated the value using the reported baseline and the change from baseline values. </p> <p>Overall, the mean Hb at 12 weeks follow‐up was on average 0.35 g/dL higher in the IPT group compared to the placebo group (MD 0.35, 95% CI 0.06 to 0.64; four trials, 1672 participants, <a href="./references#CD010767-fig-0007" title="">Analysis 1.4</a>; T² = 0.08; I² = 76%). One trial (<a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>) caused heterogeneity. If we remove this trial from the analysis, heterogeneity is reduced to 0%. </p> <p>Subgroup analysis did not show a difference between children receiving iron and children receiving no iron (Chi² = 0.89, P = 0.35, I² = 0%). </p> <p>There was also no significant difference between subgroups for areas with high endemicity versus areas with low endemicity (Chi² = 0.85, P = 0.36, I² = 0%; <a href="./references#CD010767-fig-0011" title="">Analysis 2.4</a>). </p> <p>Subgroup analysis further stratifying subgroups according to recruitment (hospital admission versus selected from community) did not show a difference between groups and we thus combined hospital admissions and community recruitments in the main analyses. </p> <p>We did not include one intervention arm of <a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>, where children received SP plus VAC, in the meta‐analysis. The mean Hb in these children was not different from the mean Hb in children that only received SP (one trial, 138 participants, <a href="./references#CD010767-fig-0014" title="">Analysis 3.3</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010767-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010767-sec-0085"></div> <section id="CD010767-sec-0086"> <h3 class="title" id="CD010767-sec-0086">Summary of main results</h3> <p>The included trials did not demonstrate a difference in mortality or hospital admissions at six months when administering IPT, compared to not administering IPT to anaemic children living in malaria‐endemic areas (<i>moderate quality evidence</i> ); and also did not demonstrate a difference in the prevalence of anaemia at 12 weeks amongst children that received IPT compared to those that did not receive IPT (<i>moderate quality evidence</i> ). IPT for anaemic children living in malaria‐endemic areas probably increases the mean change in Hb levels from baseline to follow‐up at 12 weeks (<i>moderate quality evidence</i> ); and may improve Hb levels at 12 weeks (<i>low quality evidence).</i> </p> </section> <section id="CD010767-sec-0087"> <h3 class="title" id="CD010767-sec-0087">Overall completeness and applicability of evidence</h3> <p>All six included trials were conducted in malaria‐endemic areas, four trials in seasonal and two in perennial malaria transmission areas. Three of the six trials were conducted in areas of low endemicity. Anaemic children were recruited either in hospital, where they were treated for severe anaemia, or in the community through a screening procedure. Hb levels considered eligible for inclusion in a study differed across trials. While some trials only recruited children with severe anaemia (Hb 5.0 to 8.0 g/dL; or Hb &lt; 7 g/dL), others only included children with mild anaemia (Hb 7.0 to 10.9 g/dL). In all but two trials, children received treatment for either anaemia or malaria before randomization, which might explain why the subsequent effect of IPT was not very big. We found a small, statistically significant effect on mean Hb levels at follow‐up, and on mean change in Hb from baseline to follow‐up. However, an increase in Hb levels of 0.32 g/dL at twelve weeks is too small to add a clinically significant effect on children with moderate or severe anaemia. </p> <p>In the past decade, a decrease in malaria endemicity has been recorded in most of sub‐Saharan Africa. There has been a significant decline in malaria prevalence which coincides with a decline in the transmission potentials measured through the recent <i>P. falciparum</i> infectious inoculations rates downturn by the <i>Anopheles</i> mosquito (<a href="./references#CD010767-bbs2-0036" title="KilleenGF , TamiA , KihondaJ , OkumuFO , KotasME , GrundmannH , et al. Cost‐sharing strategies combining targeted public subsidies with private‐sector delivery achieve high bed net coverage and reduced malaria transmission in Kilombero Valley, southern Tanzania. BMC Infectious Diseases2007;7:121. ">Killeen 2007</a>). These in turn have resulted in a further downturn in new malaria infections that may have contributed to the recent shift in anaemia morbidity decline in settings with malaria transmission (<a href="./references#CD010767-bbs2-0034" title="KabanywanyiAM . Pharmaco‐Epidemiology of Artemisinin‐Based Combination Therapy in the Context of Impact Evaluation of Artemether‐Lumefantrine on Malaria Morbidity and Mortality During Programmatic Implementation in Rural Tanzania [PhD thesis]. Basel, Switzerland: University of Basel, 2012. ">Kabanywanyi 2012</a>). Malaria mortality and cumulative probability of deaths have thus also continued to decline steadily (<a href="./references#CD010767-bbs2-0050" title="RumishaSF , SmithTA , MasanjaH , AbdullaS , VounatsouP . Relationship between child survival and malaria transmission: an analysis of the malaria transmission intensity and mortality burden across Africa (MTIMBA) project data in Rufiji demographic surveillance system, Tanzania. Malaria Journal2014;13:124. ">Rumisha 2014</a>). A combination of many malaria interventions have resulted in these reductions, including improved access to effective antimalarial combination therapy, vector control using LLINs and indoor residual spraying as well as intermittent presumptive treatments in infants and pregnant women (<a href="./references#CD010767-bbs2-0016" title="AlbaS , NathanR , SchulzeA , MshindaH , LengelerC . Child mortality patterns in rural Tanzania: an observational study on the impact of malaria control interventions. International Journal of Epidemiology2014;43(1):204‐15. ">Alba 2014</a>). </p> <p>The results of this Cochrane Review thus need to be interpreted in light of these changes in malaria endemicity. Of the included trials, only three were published in the last five years (<a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a>; <a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a>; <a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a>), with two of these trials having been conducted in The Gambia, where malaria endemicity is regarded as being low. The remaining trials were all published over ten years ago; one of these in an area of high malaria endemicity (<a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>) and one where, at the time of the trial, malaria endemicity was moderate to high (<a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>). There could be larger effects of IPT in areas where malaria endemicity is higher. </p> <p>In addition, the mild effect of IPT in improving Hb levels may be associated with the fact that there are other causes for severe anaemia apart from malaria. <a href="./references#CD010767-bbs2-0021" title="CalisJC , PhiriKS , FaragherEB , BrabinBJ , BatesI , CuevasLE , et al. Severe anemia in Malawian children. New England Journal of Medicine2008;358(9):888‐99. ">Calis 2008</a> found additional associations between severe anaemia and bacteraemia, hookworm, HIV infection, and Vitamin A and B12 deficiency. They also found an inverse association between iron deficiency and severe anaemia. </p> </section> <section id="CD010767-sec-0088"> <h3 class="title" id="CD010767-sec-0088">Quality of the evidence</h3> <p>We assessed the quality of the body of evidence by using the GRADE approach (<a href="./references#CD010767-bbs2-0030" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction ‐ GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. ">Guyatt 2011</a>). We made judgements on the quality of evidence for each outcome by looking at trial limitations, inconsistency, imprecision, indirectness and the likelihood of publication bias (<a href="./references#CD010767-bbs2-0019" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401‐6. ">Balshem 2011</a>). Our results show that there is moderate quality evidence that IPT did not have an effect on death or hospital admissions at six months; and anaemia at 12 weeks; and that the mean change in Hb from baseline to 12 weeks was slightly higher amongst children receiving IPT. This means that, when looking at these three outcomes, further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. We found low quality evidence that the mean Hb level at follow‐up was slightly higher amongst children receiving IPT, meaning that further research is very likely to have an important impact on our confidence in the estimate of the effect and is likely to change the estimate. We have presented the reasons for downgrading the quality of evidence in the footnotes of <a href="./full#CD010767-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD010767-sec-0089"> <h3 class="title" id="CD010767-sec-0089">Potential biases in the review process</h3> <p>We attempted to minimise bias in the review process by conducting a comprehensive search of published and unpublished literature, without language restrictions. Two review authors independently screened abstracts, extracted data and assessed risk of bias. We resolved any discrepancies by involving a third party. We were unable to create funnel plots to assess reporting biases, since less than 10 RCTs met the inclusion criteria. </p> </section> <section id="CD010767-sec-0090"> <h3 class="title" id="CD010767-sec-0090">Agreements and disagreements with other studies or reviews</h3> <p>We are not aware of another review on the treatment of anaemic children with IPT, but two recent reviews on IPT for malaria (<a href="./references#CD010767-bbs2-0042" title="MeremikwuM , DoneganS , SinclairD , EsuE , OringanjeC . Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD003756.pub4] ">Meremikwu 2012</a>; <a href="./references#CD010767-bbs2-0063" title="WilsonAL , IPTcTaskforce . A systematic review and meta‐analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS One2011;6(2):e16976. ">Wilson 2011</a>) included anaemia as one of the outcomes. Although the included children in these reviews did not necessarily have anaemia at enrolment, our findings on the prevalence of anaemia resonate with those of <a href="./references#CD010767-bbs2-0063" title="WilsonAL , IPTcTaskforce . A systematic review and meta‐analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS One2011;6(2):e16976. ">Wilson 2011</a> (RR 0.84, 95% CI 0.59 to 1.21), but are contradictory to those of <a href="./references#CD010767-bbs2-0042" title="MeremikwuM , DoneganS , SinclairD , EsuE , OringanjeC . Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD003756.pub4] ">Meremikwu 2012</a>. <a href="./references#CD010767-bbs2-0042" title="MeremikwuM , DoneganS , SinclairD , EsuE , OringanjeC . Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD003756.pub4] ">Meremikwu 2012</a> found a reduced risk of moderate anaemia (RR 0.71, 95% CI 0.52 to 0.98; 8805 participants, five trials) as well as a reduced risk of severe anaemia (RR 0.24, 95% CI 0.06 to 0.94; 5964 participants, two trials) in children with malaria receiving IPT compared to those not receiving IPT. The markedly reduced risk of anaemia in <a href="./references#CD010767-bbs2-0042" title="MeremikwuM , DoneganS , SinclairD , EsuE , OringanjeC . Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD003756.pub4] ">Meremikwu 2012</a> could be due to subgroup analysis (severe and moderate anaemia groups) which was not done in <a href="./references#CD010767-bbs2-0063" title="WilsonAL , IPTcTaskforce . A systematic review and meta‐analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS One2011;6(2):e16976. ">Wilson 2011</a>. Neither of the reviews found a significant difference in Hb levels at the end of follow‐up in children receiving IPT compared to children not receiving IPT (<a href="./references#CD010767-bbs2-0042" title="MeremikwuM , DoneganS , SinclairD , EsuE , OringanjeC . Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD003756.pub4] ">Meremikwu 2012</a>; <a href="./references#CD010767-bbs2-0063" title="WilsonAL , IPTcTaskforce . A systematic review and meta‐analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS One2011;6(2):e16976. ">Wilson 2011</a>). We found a small, statistically significant effect of IPT on Hb levels. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010767-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010767-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials." data-id="CD010767-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial." data-id="CD010767-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IPT versus placebo, Outcome 1 All‐cause mortality plus hospital admissions at 6 months." data-id="CD010767-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 IPT versus placebo, Outcome 1 All‐cause mortality plus hospital admissions at 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IPT versus placebo, Outcome 2 Children with anaemia at 12 weeks." data-id="CD010767-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 IPT versus placebo, Outcome 2 Children with anaemia at 12 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IPT versus placebo, Outcome 3 Mean change in Hb (baseline to 12 weeks)." data-id="CD010767-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 IPT versus placebo, Outcome 3 Mean change in Hb (baseline to 12 weeks).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IPT versus placebo, Outcome 4 Mean Hb at 12 weeks." data-id="CD010767-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 IPT versus placebo, Outcome 4 Mean Hb at 12 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 IPT in high versus low endemic areas, Outcome 1 All cause mortality plus hospital admissions at 6 months." data-id="CD010767-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 IPT in high versus low endemic areas, Outcome 1 All cause mortality plus hospital admissions at 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 IPT in high versus low endemic areas, Outcome 2 Children with anaemia at 12 weeks." data-id="CD010767-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 IPT in high versus low endemic areas, Outcome 2 Children with anaemia at 12 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 IPT in high versus low endemic areas, Outcome 3 Mean change in Hb (baseline to 12 weeks)." data-id="CD010767-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 IPT in high versus low endemic areas, Outcome 3 Mean change in Hb (baseline to 12 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 IPT in high versus low endemic areas, Outcome 4 Mean Hb at 12 weeks." data-id="CD010767-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 IPT in high versus low endemic areas, Outcome 4 Mean Hb at 12 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IPT plus Vitamin A and C versus IPT in the presence of iron, Outcome 1 Children with anaemia at 12 weeks." data-id="CD010767-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 IPT plus Vitamin A and C versus IPT in the presence of iron, Outcome 1 Children with anaemia at 12 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IPT plus Vitamin A and C versus IPT in the presence of iron, Outcome 2 Mean change in Hb (baseline to 12 weeks)." data-id="CD010767-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 IPT plus Vitamin A and C versus IPT in the presence of iron, Outcome 2 Mean change in Hb (baseline to 12 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010767-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/urn:x-wiley:14651858:media:CD010767:CD010767-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_t/tCD010767-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 IPT plus Vitamin A and C versus IPT in the presence of iron, Outcome 3 Mean Hb at 12 weeks." data-id="CD010767-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 IPT plus Vitamin A and C versus IPT in the presence of iron, Outcome 3 Mean Hb at 12 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/media/CDSR/CD010767/image_n/nCD010767-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010767-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table 1</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Intermittent preventive treatment compared to placebo for children with anaemia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Children with anaemia<br/> <b>Settings:</b> Malaria‐endemic areas<br/> <b>Intervention:</b> IPT (± iron and folic acid)<br/> <b>Comparison:</b> Placebo (± iron and folic acid) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> IPT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death or hospital admission</b> </p> <p><b>Follow up at 6 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>31 per 1000</b> <br/> (24 to 38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.9</b> <br/> (0.71 to 1.13) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3160<br/> (3 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2,3,4</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Children with anaemia</b> <br/> <b>(Hb</b>  <b>&lt;</b>  <b>11 g/dL)</b> </p> <p><b>Follow up at 12 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>579 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>561 per 1000</b> <br/> (510 to 620) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b> <br/> (0.88 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2237<br/> (4 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,5,6,7</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in Hb from baseline</b> </p> <p><b>Follow up: 12 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change ranged across control groups from<br/> <b>0.32 to 5.4 g/dL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the intervention groups was<br/> <b>0.32 g/dL higher</b> <br/> (0.19 to 0.45 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1672<br/> (4 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,8,9,10</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean Hb</b> </p> <p><b>Follow up at 12 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean Hb concentration ranged across control groups from<br/> <b>9.91 to 10.7 g/dL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean Hb concentration in the intervention groups was<br/> <b>0.35 g/dL higher</b> <br/> (0.06 to 0.64 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1672<br/> (4 trials) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>8,9,10,11</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median control group risk across trials. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>IPT:</b> intermittent preventive treatment; <b>AL:</b> artemether lumefantrine. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> No serious risk of bias: The largest trial was at low risk of bias. The two smaller trials were at high risk of attrition bias, but exclusion of these trials does not change the result.<br/> <sup>2</sup> No serious inconsistency: Statistical heterogeneity was low.<br/> <sup>3</sup> No serious indirectness: The three trials were conducted in the Gambia, Kenya and Malawi, one trial gave IPT (AL monthly) to children discharged from hospital following severe malarial anaemia, and two trials gave IPT (SP monthly) to anaemic children attending hospital, outpatient clinics or recruited in the community. There was no significant result for subgroup differences between areas with high versus areas with low endemicity.<br/> <sup>4</sup> Downgraded by 1 for serious imprecision: The 95% CI around the absolute risk difference is very narrow and excludes clinically important effects. However, much larger trials would be necessary to fully exclude small benefits with IPT.<br/> <sup>5</sup> Downgraded by 1 for serious risk of bias: high risk of attrition bias for <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> and <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>.<br/> <sup>6</sup> No serious indirectness: All the trials gave IPT (SP) monthly to anaemic children attending hospital, outpatient clinics or recruited in the community. There was no significant result for subgroup differences between areas with high versus areas with low endemicity.<br/> <sup>7</sup> No serious imprecision: No effect was seen and the meta‐analysis is adequately powered to detect an effect. </p> <p><sup>8</sup> No serious imprecision. A small effect was seen although this disappears when we removed trials at high risk of bias from the analysis.<br/> <sup>9</sup> Downgraded by 1 for serious risk of bias: High risk for attrition bias for <a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> and <a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>.<br/> <sup>10</sup> No serious indirectness: Three trials gave IPT (SP) monthly and one trial gave CQ weekly to anaemic children attending hospital, outpatient clinics or recruited in the community. There was no significant result for subgroup differences between areas with high versus areas with low endemicity.<br/> <sup>11</sup> Downgraded for serious inconsistency: Heterogeneity (I² statistic = 76%; Chi² statistic = 16.93; P = 0.002) is present. One trial is an outlier (<a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table 1</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010767-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of trial characteristics</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trial</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sample size (n randomized)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1200</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>554</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1431</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>328</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>238</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Country</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The Gambia (Banjul)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The Gambia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenya (Western Kenya)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Malawi (southern Malawi)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Kenya (Eastern province)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tanzania (Kigoma region)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endemicity</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>low*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>low*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>high*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>high*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>low*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>moderate/high (50% parasitaemia)**</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Age</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months to 9 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 to 72 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 to 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 59 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 to 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 to 59 months</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Anaemia</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb &lt; 7 g/dL</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb 69 to 110 g/L</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb 7.0 to 10.9 g/dL</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>All children treated for severe malarial anaemia with transfusion and completed the course of intravenous quinine with subsequent Hb &gt; 5g/dL </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb 60 to 110 g/L</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb 5.0 to 8.0 g/dL</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Malaria</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not criteria for inclusion. Children with malaria were treated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncomplicated malaria</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No malaria (aparasitaemic) or parasite counts &lt; 20,000 parasites/mm<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No clinical malaria</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not described as part of eligibility</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Recruitment</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital or OPD admission</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Active and passive case finding of children in community</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community: resident children screened</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital admissions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Community: randomly selected</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health care worker diagnosed children with clinical anaemia and referred them to the trial </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Trial intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD010767-list-0005"> <li> <p>IPT (SP)</p> </li> <li> <p>Placebo</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD010767-list-0006"> <li> <p>IPT (CQ)</p> </li> <li> <p>Placebo</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD010767-list-0007"> <li> <p>IPT (SP) + iron</p> </li> <li> <p>IPT (SP) + iron placebo</p> </li> <li> <p>Iron + IPT placebo</p> </li> <li> <p>Iron placebo + IPT placebo</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD010767-list-0008"> <li> <p>IPT(post discharge): AL</p> </li> <li> <p>Placebo</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD010767-list-0009"> <li> <p>IPT (SP) + iron</p> </li> <li> <p>IPT (SP) + iron placebo</p> </li> <li> <p>Iron + IPT placebo</p> </li> <li> <p>Iron placebo + IPT placebo</p> </li> </ol> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ol id="CD010767-list-0010"> <li> <p>Vitamin placebo 3X per week</p> </li> <li> <p>Vitamin placebo + IPT (SP)</p> </li> <li> <p>VAC + IPT (SP)</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Iron and other supplementation during trial period (all participants)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: oral iron for 28 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No ‐ part of trial intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No – part of trial intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: Iron and folic acid for 12 weeks</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Baseline treatment for all participants</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some were treated with quinine and SP or CQ and SP. Not all children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Either CQ and SP or AL</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single dose of SP</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 day course of AL<br/> in hospital (6 doses) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single dose of SP; mebendazole for participants &gt; 12 months</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>*endemicity derived from the Malaria Atlas Project (<a href="./references#CD010767-bbs2-0025" title="GethingPW , PatilAP , SmithDL , GuerraCA , ElyazarIRF , JohnstonGL , et al. A new world malaria map: Plasmodium falciparum endemicity in 2010. Malaria Journal2011;10:378. ">Gething 2011</a>). </p> <p>**as reported in the trial (<a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a>). </p> <p>Abbreviations:</p> <p>Hb: Haemoglobin</p> <p>OPD: Out patient department</p> <p>IPT: Intermittent preventive treatment</p> <p>SP:Sulfadoxine‐pyrimethamine</p> <p>CQ: Chloroquine</p> <p>AL: Arthemeter‐lumefantrine</p> <p>VAC: Vitamin A and C</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of trial characteristics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010767-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of outcomes reported in trials</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Outcomes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Trial</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0001" title="BojangKA , MilliganPJM , ConwayDJ , Sisay‐JoofF , JallowM , NwakanmaDC , et al. Prevention of the recurrence of anaemia in Gambian children following discharge from hospital. PLoS ONE2010;5(6):e11227. ">Bojang 2010 GMB</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0002" title="CoxSE , NwenekaCV , DohertyCP , FulfordAJ , MooreSE , PrenticeAM . Randomised controlled trial of weekly chloroquine to re‐establish normal erython iron flux and haemoglobin recovery in postmalarial anaemia. BMJ Open2013;3(7):e002666. ">Cox 2013 GMB</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0003" title="DesaiMR , MeiVJ , KariukiSK , WannemuehlerKA , Phillips‐HowardPA , NahlenBL , et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine‐pyrimethamine for the treatment of mild childhood anaemia in Western Kenya.. Journal of Infectious Diseases2003;187(4):658‐66. ">Desai 2003 KEN</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0004" title="PhiriK , EsanM , vanHensbroekMB , KhairallahC , FaragherB , ter KuileFO . Intermittent preventive therapy for malaria with monthly artemether‐lumefantrine for the post‐discharge management of severe anaemia in children aged 4‐59 months in southern Malawi: a multicentre, randomised, placebo‐controlled trial.. Lancet Infectious Diseases2012;12(3):191‐200. ">Phiri 2012 MWI</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0006" title="VerhoefH , WestCE , NzyukoSM , deVogelS , van derValkR , WangaMA , et al. Intermittent administration of iron and sulfadoxine‐pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet2002;360(9337):908‐14. ">Verhoef 2002 KEN</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010767-bbs2-0005" title="TomashekKM , WoodruffBA , GotwayCA , BlolandP , MbarukuG . Randomised intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania. American Journal of Tropical Medicine and Hygiene2001;64(3‐4):164‐71. ">Tomashek 2001 TNZ</a> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b> Haematological outcomes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Mean Hb at end of follow‐up</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean Hb level at end of transmission period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb concentration (measured in g/dL)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hb concentration at the end of follow‐up (12 weeks)*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean Hb</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Mean change of Hb from baseline to follow‐up </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean change of Hb from baseline to follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Children with anaemia at follow‐up </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children with moderate or severe anaemia at the end of the transmission period* </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hematological recovery (Hb ≥ 11g/dL before or at week 12)</p> <p>Severe anaemia (Hb &lt; 7 g/dL before or at week 12)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anaemia (Hb &lt; 11.0 g/dL)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prevalence of anaemia (Hb &lt; 11.0 g/dL)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Other</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in erythropoietic response</p> <p>Hb change from baseline to follow‐up in two placebo arms to investigate the effect of antimalarial therapy </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MCV (measured in fL)</p> <p>sTfR concentration (measured in µg/mL)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iron deficiency (serum ferritin concentration &lt; 12 µg/L)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean TfR level</p> <p>Prevalence of iron deficiency (TfR &lt; 8.5 µg/mL)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b> Malaria outcomes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Clinical malaria</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical episodes of malaria during the surveillance period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical malaria (axillary temperature 37.5 with co‐existing malaria parasitaemia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children with at least one malaria attack (defined as presence of fever, that is temperature ≥ 37.5°C, and a positive dipstick result)* </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Malaria parasitaemia</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prevalence of parasitaemia and splenomegaly</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prevalence of submicroscopic malaria parasitaemia</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prevalence of malaria parasitaemia</p> <p>Parasite density (parasites/mm<sup>3</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Hospital admissions or clinic visits related to malaria</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hospital re‐admission because of all‐cause severe anaemia or severe malaria</p> <p>Clinic visits because of microscopically confirmed non‐severe malaria</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Other</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to first occurrence of malaria attack</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> All‐cause mortality and hospital admission </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Composite outcome of all‐cause mortality and hospital readmission because of all‐cause severe anaemia or severe malaria between 1 and 6 months* </p> <p>All‐cause hospital admission</p> <p>All‐cause mortality</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Visits to healthcare facilities</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient attendance</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinic visits (incidence, number of episodes)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause sick child clinic visits</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Other</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nutritional status at the end oft he transmission period</p> <p>Compliance with treatment regimen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in urinary neopterin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse drug reactions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>*indicates primary outcomes</p> <p>Abbreviations:</p> <p>Hb: haemoglobin</p> <p>TfR: transferrin receptor</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of outcomes reported in trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/full#CD010767-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010767-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">IPT versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality plus hospital admissions at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.71, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1474</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.56, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 No iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1686</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.68, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Children with anaemia at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.88, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1801</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.74, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>436</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.96, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mean change in Hb (baseline to 12 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1672</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.19, 0.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.15, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 No iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.12, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mean Hb at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1672</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.06, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.08, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 No iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [‐0.10, 1.23]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">IPT versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010767-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">IPT in high versus low endemic areas</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All cause mortality plus hospital admissions at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.71, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 High endemicity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1960</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.71, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Low endemicity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.43, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Children with anaemia at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.88, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 High endemicity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.90, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Low endemicity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1528</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.74, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mean change in Hb (baseline to 12 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1672</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.19, 0.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 High endemicity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.17, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low endemicity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1031</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.10, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mean Hb at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1672</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.06, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High endemicity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>641</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [‐0.03, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low endemicity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1031</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 0.40]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">IPT in high versus low endemic areas</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010767-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">IPT plus Vitamin A and C versus IPT in the presence of iron</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Children with anaemia at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.75, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean change in Hb (baseline to 12 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.48, 0.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mean Hb at 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.65, 0.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">IPT plus Vitamin A and C versus IPT in the presence of iron</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010767.pub2/references#CD010767-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010767.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010767-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010767-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="ru#CD010767-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010767\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010767\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010767\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010767\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010767\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010767.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010767.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010767.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010767.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010767.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720129145"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010767.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720129148"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010767.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df9a30a929377',t:'MTc0MDcyMDEyOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 